| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ | Chief Operating Officer | Employee Performance Stock Option (Right to Buy) | 900,000 | $1,980,000 | $2.20 | 28 Apr 2025 | Direct |
| HERON THERAPEUTICS, INC. /DE/ | Chief Operating Officer | Employee Stock Option (Right to Buy) | 500,000 | $1,100,000 | $2.20 | 28 Apr 2025 | Direct |
| HERON THERAPEUTICS, INC. /DE/ | Chief Operating Officer | Restricted Stock Units | 188,315 | 30 Jan 2026 | Direct | ||
| HERON THERAPEUTICS, INC. /DE/ | Chief Operating Officer | Performance Stock Units | 188,314 | 30 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS, INC. /DE/ | 30 Jan 2026 | 2 | $0 | 4 | Chief Operating Officer | 03 Feb 2026, 10:00 |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | 06 May 2025 | 1 | $0 | 4 | Chief Operating Officer | 07 May 2025, 12:20 |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | 28 Apr 2025 | 0 | $0 | 4 | Chief Operating Officer | 29 Apr 2025, 12:47 |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | 28 Apr 2025 | 0 | $0 | 3 | Chief Operating Officer | 29 Apr 2025, 12:46 |